Iterative Health Accelerates Clinical Trial Recruitment Through Partnership with Florida Research Institute

Partnership brings Iterative Health’s artificial intelligence technology to patients across the Florida region

Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, announced that it has partnered with Florida Research Institute (FRI), a leader in gastroenterology and hepatology research, to bring its AI-Recruitment (AIR) technology to the Florida region to standardize endoscopic scoring and give patients better access to more precise therapeutics by way of clinical trials. The implementation of AIR will aid in the recruitment of patients to clinical trials focused on advancing therapies for inflammatory bowel disease (IBD). The two organizations will help to democratize access to novel IBD therapeutics for all patients, regardless of where they receive care.

AiThority Interview : AiThority Interview with João Graça, Co-founder and CTO at Unbabel

“We’re thrilled to partner with Iterative Health in order to advance patient care and increase access to clinical trials for patients in Florida,” said Dr. Souvik Sarkar, Principal Investigator and Medical Director at Florida Research Institute. “AIR will streamline the clinical trial identification process, increasing patients’ ability to participate in trials that may ultimately lead to better treatments and care. Both organizations are passionate about reducing healthcare disparities, and together, we look forward to helping democratize GI care.”

Florida Research Institute brings advanced therapies to those struggling with liver and gastrointestinal diseases and provides advanced patient care through a highly skilled team of more than twenty clinical research professionals. FRI was founded by Florida Digestive Health Specialists, one of the largest single-specialty gastroenterology networks in the state, and is connected to a library of thousands of local, pre-vetted, eligible potential clinical trial participants. The database has allowed the organization to conduct a multitude of trials in various therapeutic areas and work toward their mission with a state-of-the-art research program.

Read More Interview: AiThority Interview with Anthony Katsur, Chief Executive Officer at IAB Tech Lab

“Our ultimate mission at Iterative Health is to use computer vision-based technology to reduce disparities in healthcare, and we’re excited to collaborate with an organization like FRI that has a shared goal,” said Scott Lish, VP of Network Expansion at Iterative Health. “This partnership with Dr. Sarkar and his network of gastroenterologists, combined with our existing relationships with leading pharmaceutical manufacturers to support their active clinical trials, will accelerate the development process of novel IBD therapeutics and improve patient access.”

“With this partnership, we’ll be able to utilize AIR technology in our practice, and when combined with our cutting-edge research program this will enable us to advance medicine and GI care for years to come,” says Dr. Brent Murchie, IBD specialist at FRI. “Clinical trials are necessary for the development of new treatments, and we’ll be able to more quickly and accurately identify potential participants for trials, improving and optimizing our clinical trial capabilities.”

 Latest Interview Insights : AiThority Interview with Ritu Bhargava, Chief Product Officer at SAP CX

 [To share your insights with us, please write to sghosh@martechseries.com]